EcoDrugPlus

Discoidin Domain Receptor Family, Member 2

Ensembl ID : ENSMSIG00000012540
Gene Symbol: DDR2
1 Cross references
280 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSMSIG00000007538
Gene Symbol: DRD1
1 Cross references
276 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSMSIG00000013494
Gene Symbol: DRD2
1 Cross references
234 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSMSIG00000004875
Gene Symbol: DRD3
1 Cross references
221 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSMSIG00000027360
Gene Symbol: DRD4
1 Cross references
261 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSMSIG00000025736
Gene Symbol: DRD5
1 Cross references
201 Possible Orthologues:

Echinoderm Microtubule Associated Protein Like 4

Ensembl ID : ENSMSIG00000011879
Gene Symbol: EML4
1 Cross references
224 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSMSIG00000022087
Gene Symbol: ENPP2
1 Cross references
242 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 2

Ensembl ID : ENSMSIG00000027049
Gene Symbol: EGLN2
1 Cross references
205 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSMSIG00000004731
Gene Symbol: EGLN3
1 Cross references
222 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSMSIG00000002142
Gene Symbol: ELANE
1 Cross references
117 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSMSIG00000010616
Gene Symbol: EPAS1
1 Cross references
237 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).